For example, palmitate levels are higher in metastatic PCa patients who respond poorly to abiraterone, and Cav‐1 promotes hormone resistance by up‐regulating ACC1‐FASN and palmitate synthesis under ADT [32]. The gene discussed is CAV1; the disease is posterior cortical atrophy.